메뉴 건너뛰기




Volumn 5, Issue 7, 2006, Pages 549-563

Targeting signal transduction as a strategy to treat inflammatory diseases

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ADALIMUMAB; ANTIINFLAMMATORY AGENT; BORTEZOMIB; CILOMILAST; DORAMAPIMOD; ERLOTINIB; ETANERCEPT; EVEROLIMUS; FINGOLIMOD; GEFITINIB; IMATINIB; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLIXIMAB; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NATALIZUMAB; PROSTAGLANDIN; RITUXIMAB; ROFECOXIB; ROFLUMILAST; SCIO 469; SILDENAFIL; STAT PROTEIN; TEMSIROLIMUS; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR; TRASTUZUMAB; TUMOR NECROSIS FACTOR; UNINDEXED DRUG;

EID: 33745679123     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd2070     Document Type: Review
Times cited : (248)

References (96)
  • 1
    • 2442590862 scopus 로고    scopus 로고
    • New drugs for rheumatoid arthritis
    • Olsen, N. J. & Stein, C. M. New drugs for rheumatoid arthritis. N. Engl. J. Med. 350, 2167-2179 (2004).
    • (2004) N. Engl. J. Med. , vol.350 , pp. 2167-2179
    • Olsen, N.J.1    Stein, C.M.2
  • 2
    • 15044348210 scopus 로고    scopus 로고
    • Cardiovascular hazard and non-steroidal anti-inflammatory drugs
    • Wang, D., Wang, M., Cheng, Y. & Fitzgerald, G. A. Cardiovascular hazard and non-steroidal anti-inflammatory drugs. Curr. Opin. Pharmacol. 5, 204-210 (2005).
    • (2005) Curr. Opin. Pharmacol. , vol.5 , pp. 204-210
    • Wang, D.1    Wang, M.2    Cheng, Y.3    Fitzgerald, G.A.4
  • 3
    • 10944229392 scopus 로고    scopus 로고
    • Does safety make a difference in selecting the right TNF antagonist?
    • Fleischmann, R. & Yocum, D. Does safety make a difference in selecting the right TNF antagonist? Arthritis Res. Ther. 6, S12-S18 (2004).
    • (2004) Arthritis Res. Ther. , vol.6
    • Fleischmann, R.1    Yocum, D.2
  • 4
    • 2942537697 scopus 로고    scopus 로고
    • Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
    • Edwards, J. C. et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N. Engl. J. Med. 350, 2572-2581 (2004).
    • (2004) N. Engl. J. Med. , vol.350 , pp. 2572-2581
    • Edwards, J.C.1
  • 5
    • 0242574700 scopus 로고    scopus 로고
    • Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig
    • Kremer, J. M. et al. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N. Engl. J. Med. 349, 1907-1915 (2003).
    • (2003) N. Engl. J. Med. , vol.349 , pp. 1907-1915
    • Kremer, J.M.1
  • 6
    • 27644441529 scopus 로고    scopus 로고
    • Natalizumab induction and maintenance therapy for Crohn's disease
    • Sandborn, W. J. et al. Natalizumab induction and maintenance therapy for Crohn's disease. N. Engl. J. Med. 353, 1912-1925 (2005).
    • (2005) N. Engl. J. Med. , vol.353 , pp. 1912-1925
    • Sandborn, W.J.1
  • 7
    • 4444330207 scopus 로고    scopus 로고
    • The potential of PDE4 inhibitors in respiratory disease
    • Spina, D. The potential of PDE4 inhibitors in respiratory disease. Curr. Drug Targets Inflamm. Allergy 3, 231-236 (2004).
    • (2004) Curr. Drug Targets Inflamm. Allergy , vol.3 , pp. 231-236
    • Spina, D.1
  • 8
    • 33644811309 scopus 로고    scopus 로고
    • Phosphodiesterase inhibitors in airways disease
    • Chung, K. F. Phosphodiesterase inhibitors in airways disease. Eur. J. Pharmacol. 533, 110-117 (2006).
    • (2006) Eur. J. Pharmacol. , vol.533 , pp. 110-117
    • Chung, K.F.1
  • 9
    • 0033553509 scopus 로고    scopus 로고
    • Cyclic GMP phosphodiesterase-5: Target of sildenafil
    • Corbin, J. D. & Francis, S. H. Cyclic GMP phosphodiesterase-5: Target of sildenafil. J. Biol. Chem. 274, 13729-13732 (1999).
    • (1999) J. Biol. Chem. , vol.274 , pp. 13729-13732
    • Corbin, J.D.1    Francis, S.H.2
  • 10
    • 33644793664 scopus 로고    scopus 로고
    • Gefitinib: Current and future status in cancer therapy
    • Herbst, R. S. & Kies, M. S. Gefitinib: Current and future status in cancer therapy. Clin. Adv. Hematol. Oncol. 1, 466-472 (2003).
    • (2003) Clin. Adv. Hematol. Oncol. , vol.1 , pp. 466-472
    • Herbst, R.S.1    Kies, M.S.2
  • 11
    • 0346651121 scopus 로고    scopus 로고
    • Final results from a Phase II study of erlotinib monotherapy in patients with advanced non-small cell lung cancer following failure of platinum-based chemotherapy
    • Perez-Soler, R. et al. Final results from a Phase II study of erlotinib monotherapy in patients with advanced non-small cell lung cancer following failure of platinum-based chemotherapy. Lung Cancer 41, S246 (2003).
    • (2003) Lung Cancer , vol.41
    • Perez-Soler, R.1
  • 12
    • 26844503270 scopus 로고    scopus 로고
    • Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
    • Piccart-Gebhart, M. J. et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N. Engl. J. Med. 353, 1659-1672 (2005).
    • (2005) N. Engl. J. Med. , vol.353 , pp. 1659-1672
    • Piccart-Gebhart, M.J.1
  • 13
    • 0035810142 scopus 로고    scopus 로고
    • Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukaemia and acute lymphoblastic leukaemia with the Philadelphia chromosome
    • Druker, B. J. et al. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukaemia and acute lymphoblastic leukaemia with the Philadelphia chromosome. N. Engl. J. Med. 344, 1038-1042 (2001).
    • (2001) N. Engl. J. Med. , vol.344 , pp. 1038-1042
    • Druker, B.J.1
  • 14
    • 0023433699 scopus 로고
    • The role of interleukin 1 in the pathogenesis of rheumatoid arthritis
    • Miossec, P. The role of interleukin 1 in the pathogenesis of rheumatoid arthritis. Clin. Exp. Rheumatol. 5, 305-308 (1987).
    • (1987) Clin. Exp. Rheumatol. , vol.5 , pp. 305-308
    • Miossec, P.1
  • 15
    • 0026602739 scopus 로고
    • TNF-α - A pivotal role in rheumatoid arthritis?
    • Brennan, F. M., Maini, R. N. & Feldmann, M. TNF-α - A pivotal role in rheumatoid arthritis? Br. J. Rheumatol. 31, 293-298 (1992).
    • (1992) Br. J. Rheumatol. , vol.31 , pp. 293-298
    • Brennan, F.M.1    Maini, R.N.2    Feldmann, M.3
  • 16
    • 0025774776 scopus 로고
    • Drosophila Toll and IL-1 receptor
    • Gay, N. J. & Keith, F. J. Drosophila Toll and IL-1 receptor. Nature 351, 355-356 (1991).
    • (1991) Nature , vol.351 , pp. 355-356
    • Gay, N.J.1    Keith, F.J.2
  • 17
    • 0031801957 scopus 로고    scopus 로고
    • Signal transduction pathways activated by the IL-1 receptor family: Ancient signaling machinery in mammals, insects, and plants
    • O'Neill, L. A. & Greene, C. Signal transduction pathways activated by the IL-1 receptor family: Ancient signaling machinery in mammals, insects, and plants. J. Leukoc. Biol. 63, 650-657 (1998).
    • (1998) J. Leukoc. Biol. , vol.63 , pp. 650-657
    • O'Neill, L.A.1    Greene, C.2
  • 18
    • 0042493163 scopus 로고    scopus 로고
    • Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases
    • O'Neill, L. A. Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases. Curr. Opin. Pharmacol. 3, 3396-3403 (2003).
    • (2003) Curr. Opin. Pharmacol. , vol.3 , pp. 3396-3403
    • O'Neill, L.A.1
  • 19
    • 0022930702 scopus 로고
    • Inducibility of κ-immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism
    • Sen, R. & Baltimore, D. Inducibility of κ-immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism. Cell 47, 921-928 (1986).
    • (1986) Cell , vol.47 , pp. 921-928
    • Sen, R.1    Baltimore, D.2
  • 20
    • 0342742310 scopus 로고
    • Tumor necrosis factor-α and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor κB
    • Osborn, L., Kunkel, S. & Nabel, G. J. Tumor necrosis factor-α and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor κB. Proc. Natl Acad. Sci. USA 86, 2336-2340 (1989).
    • (1989) Proc. Natl Acad. Sci. USA , vol.86 , pp. 2336-2340
    • Osborn, L.1    Kunkel, S.2    Nabel, G.J.3
  • 21
    • 30044442866 scopus 로고    scopus 로고
    • How Toll-like receptors signal: What we know and what we don't know
    • O'Neill, L. A. How Toll-like receptors signal: What we know and what we don't know. Curr. Opin. Immunol. 18, 3-9 (2006).
    • (2006) Curr. Opin. Immunol. , vol.18 , pp. 3-9
    • O'Neill, L.A.1
  • 22
    • 22444433175 scopus 로고    scopus 로고
    • NLRs join TLRs as innate sensors of pathogens
    • Martinon, F. & Tschopp, J. NLRs join TLRs as innate sensors of pathogens. Trends Immunol. 26, 447-454 (2005).
    • (2005) Trends Immunol. , vol.26 , pp. 447-454
    • Martinon, F.1    Tschopp, J.2
  • 23
    • 5644277476 scopus 로고    scopus 로고
    • Interleukin-17 family members and inflammation
    • Kolls, J. K. & Linden, A. Interleukin-17 family members and inflammation. Immunity 21, 467-476 (2004).
    • (2004) Immunity , vol.21 , pp. 467-476
    • Kolls, J.K.1    Linden, A.2
  • 24
    • 20644455960 scopus 로고    scopus 로고
    • Control of lymphocyte development by nuclear factor-κB
    • Siebenlist, U., Brown, K. & Claudio, E. Control of lymphocyte development by nuclear factor-κB. Nature Rev. Immunol. 5, 435-445 (2005).
    • (2005) Nature Rev. Immunol. , vol.5 , pp. 435-445
    • Siebenlist, U.1    Brown, K.2    Claudio, E.3
  • 25
    • 27844487939 scopus 로고    scopus 로고
    • The NF-κB pathway
    • Moynagh, P. N. The NF-κB pathway. J. Cell Sci. 118, 4589-4592 (2005).
    • (2005) J. Cell Sci. , vol.118 , pp. 4589-4592
    • Moynagh, P.N.1
  • 26
    • 9144275033 scopus 로고    scopus 로고
    • Activation of IKKα target genes depends on recognition of specific κB binding sites by RelB:p52 dimers
    • Bonnizzi, G. et al. Activation of IKKα target genes depends on recognition of specific κB binding sites by RelB:p52 dimers. EMBO J. 23, 4202-4210 (2004).
    • (2004) EMBO J. , vol.23 , pp. 4202-4210
    • Bonnizzi, G.1
  • 27
    • 0346505340 scopus 로고    scopus 로고
    • The IKK NF-κB system: A treasure trove for drug development
    • Karin, M., Yamamoto, Y. & May Wang, Q. The IKK NF-κB system: A treasure trove for drug development. Nature Rev. Drug Discov. 3, 17-26 (2004).
    • (2004) Nature Rev. Drug Discov. , vol.3 , pp. 17-26
    • Karin, M.1    Yamamoto, Y.2    May Wang, Q.3
  • 28
    • 14944353807 scopus 로고    scopus 로고
    • Amelioration of acute inflammation by systemic administration of a cell-permeable peptide inhibitor of NF-κB activation
    • di Meglio, P., Ianaro, A. & Ghosh, S. Amelioration of acute inflammation by systemic administration of a cell-permeable peptide inhibitor of NF-κB activation. Arthritis Rheum. 52, 951-958 (2005).
    • (2005) Arthritis Rheum. , vol.52 , pp. 951-958
    • di Meglio, P.1    Ianaro, A.2    Ghosh, S.3
  • 29
    • 26444605834 scopus 로고    scopus 로고
    • IKK/NF-κB signaling: Balancing life and death - A new approach to cancer therapy
    • Luo, J. L., Kamata, H. & Karin, M. IKK/NF-κB signaling: Balancing life and death - a new approach to cancer therapy. J. Clin. Invest. 115, 2625-2632 (2005).
    • (2005) J. Clin. Invest. , vol.115 , pp. 2625-2632
    • Luo, J.L.1    Kamata, H.2    Karin, M.3
  • 30
    • 29344437557 scopus 로고    scopus 로고
    • Proteasome inhibition: A new approach for the treatment of malignancies
    • E61-E66
    • Spano, J. P., Bay, J. O., Blay, J. Y. & Rixe, O. Proteasome inhibition: a new approach for the treatment of malignancies. Bull. Cancer 92, E61-E6, 945-952 (2005).
    • (2005) Bull. Cancer , vol.92 , pp. 945-952
    • Spano, J.P.1    Bay, J.O.2    Blay, J.Y.3    Rixe, O.4
  • 31
    • 33745641276 scopus 로고    scopus 로고
    • Proteolix, Inc. Proteolix Programs [online]
    • Proteolix, Inc. Proteolix Programs [online], (2006).
    • (2006)
  • 32
    • 0027936755 scopus 로고
    • A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells
    • Han, J., Lee, J. D., Bibbs, L. & Ulevitch, R. J. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265, 808-811 (1994).
    • (1994) Science , vol.265 , pp. 808-811
    • Han, J.1    Lee, J.D.2    Bibbs, L.3    Ulevitch, R.J.4
  • 33
    • 0028015872 scopus 로고
    • Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27
    • Freshney, N. W. et al. Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell 78, 1039-1049 (1994).
    • (1994) Cell , vol.78 , pp. 1039-1049
    • Freshney, N.W.1
  • 34
    • 0028605318 scopus 로고
    • A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
    • Lee, J. C. et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372, 739-746 (1994).
    • (1994) Nature , vol.372 , pp. 739-746
    • Lee, J.C.1
  • 35
    • 0036435213 scopus 로고    scopus 로고
    • Transcriptional and post-transcriptional control of gene expression in inflammation
    • Kracht, M. & Saklatvala, J. Transcriptional and post-transcriptional control of gene expression in inflammation. Cytokine 20, 91-106 (2002).
    • (2002) Cytokine , vol.20 , pp. 91-106
    • Kracht, M.1    Saklatvala, J.2
  • 36
    • 27744577296 scopus 로고    scopus 로고
    • TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo
    • Shim, J. H. et al. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 19, 2668-2681 (2005).
    • (2005) Genes Dev. , vol.19 , pp. 2668-2681
    • Shim, J.H.1
  • 37
    • 3142546235 scopus 로고    scopus 로고
    • The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisation
    • Dean, J. L., Sully, G., Clark, A. R. & Saklatvala, J. The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisation. Cell Signal. 16, 1113-1121 (2004).
    • (2004) Cell Signal. , vol.16 , pp. 1113-1121
    • Dean, J.L.1    Sully, G.2    Clark, A.R.3    Saklatvala, J.4
  • 39
    • 27744582136 scopus 로고    scopus 로고
    • Pathway to the clinic: Inhibition of p38 MAP kinase. A review of ten chemotypes selected for development
    • Goldstein, D. M. & Gabriel, T. Pathway to the clinic: Inhibition of p38 MAP kinase. A review of ten chemotypes selected for development. Curr. Top. Med. Chem. 5, 1017-1029 (2005).
    • (2005) Curr. Top. Med. Chem. , vol.5 , pp. 1017-1029
    • Goldstein, D.M.1    Gabriel, T.2
  • 40
    • 33745636753 scopus 로고    scopus 로고
    • Vertex reports investigational p38 MAP kinase inhibitor, VX-702, meets primary objectives in Phase II clinical study in rheumatoid arthritis
    • Vertex, Inc. [online]
    • Vertex, Inc. Vertex reports investigational p38 MAP kinase inhibitor, VX-702, meets primary objectives in Phase II clinical study in rheumatoid arthritis [online], (2006).
    • (2006)
  • 41
    • 23944466208 scopus 로고    scopus 로고
    • Context-specific inhibition of JNKs: Overcoming the dilemma of protection and damage
    • Waetzig, V. & Herdegen, T. Context-specific inhibition of JNKs: overcoming the dilemma of protection and damage. Trends Pharmacol. Sci. 26, 455-461 (2005).
    • (2005) Trends Pharmacol. Sci. , vol.26 , pp. 455-461
    • Waetzig, V.1    Herdegen, T.2
  • 42
    • 0038004740 scopus 로고    scopus 로고
    • Targeting JNK for therapeutic benefit: From junk to gold
    • Manning, A. M. & Davis, R. J. Targeting JNK for therapeutic benefit: from junk to gold. Nature Rev. Drug Discov. 2, 554-565 (2003).
    • (2003) Nature Rev. Drug Discov. , vol.2 , pp. 554-565
    • Manning, A.M.1    Davis, R.J.2
  • 43
    • 24444465749 scopus 로고    scopus 로고
    • The effects of a selective c-Jun N-terminal kinase inhibition in a sensitized Brown Norway rat model of allergic asthma
    • Eynott, P. R., Adcock, I. M. & Chung, P. The effects of a selective c-Jun N-terminal kinase inhibition in a sensitized Brown Norway rat model of allergic asthma. Am. J. Respir. Crit. Care Med. 49, S102 (2001).
    • (2001) Am. J. Respir. Crit. Care Med. , vol.49
    • Eynott, P.R.1    Adcock, I.M.2    Chung, P.3
  • 44
    • 0032872521 scopus 로고    scopus 로고
    • Jun-N-terminal kinase in rheumatoid arthritis
    • Han, Z. et al. Jun-N-terminal kinase in rheumatoid arthritis. J. Pharm. Exp. Ther. 291, 124-130 (1999).
    • (1999) J. Pharm. Exp. Ther. , vol.291 , pp. 124-130
    • Han, Z.1
  • 45
    • 0037126628 scopus 로고    scopus 로고
    • Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1
    • Kassel, O. et al. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J. 20, 7108-7116 (2001).
    • (2001) EMBO J. , vol.20 , pp. 7108-7116
    • Kassel, O.1
  • 46
    • 0036841288 scopus 로고    scopus 로고
    • Dexamethasone causes sustained expression of MKP-1 and phosphatase-mediated inhibition of MAPK p38
    • Lasa, M., Abraham, S. M., Boucheron, C., Saklatvala, J. & Clark, A. R. Dexamethasone causes sustained expression of MKP-1 and phosphatase-mediated inhibition of MAPK p38. Mol. Cell. Biol. 22, 7802-7811 (2002).
    • (2002) Mol. Cell. Biol. , vol.22 , pp. 7802-7811
    • Lasa, M.1    Abraham, S.M.2    Boucheron, C.3    Saklatvala, J.4    Clark, A.R.5
  • 47
  • 48
    • 0242332186 scopus 로고    scopus 로고
    • Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor
    • Changelian, P. S. et al. Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor. Science 302, 875-878 (2003).
    • (2003) Science , vol.302 , pp. 875-878
    • Changelian, P.S.1
  • 49
    • 25444519432 scopus 로고    scopus 로고
    • Targeting interleukin-15 in patients with rheumatoid arthritis: A proof-of-concept study
    • Baslund, B. et al. Targeting interleukin-15 in patients with rheumatoid arthritis: A proof-of-concept study. Arthritis Rheum. 52, 2686-2692 (2005).
    • (2005) Arthritis Rheum. , vol.52 , pp. 2686-2692
    • Baslund, B.1
  • 50
    • 32644441926 scopus 로고    scopus 로고
    • A randomized, multicenter, double-blind, placebo-controlled phase 2 trial of ISA247 in patients with chronic plaque psoriasis
    • Bissonnette, R. et al. A randomized, multicenter, double-blind, placebo-controlled phase 2 trial of ISA247 in patients with chronic plaque psoriasis. J. Am. Acad. Dermatol. 54, 472-478 (2006).
    • (2006) J. Am. Acad. Dermatol. , vol.54 , pp. 472-478
    • Bissonnette, R.1
  • 51
    • 33745124738 scopus 로고    scopus 로고
    • Role of sphingosine 1-phosphate receptor type I in lymphocyte egress from secondary lymphoid tissues and thymus
    • Chiba, K., Matsuyuki, H., Maeda, Y. & Sugahara, K. Role of sphingosine 1-phosphate receptor type I in lymphocyte egress from secondary lymphoid tissues and thymus. Cell. Mol. Immunol. 3, 11-19 (2006).
    • (2006) Cell. Mol. Immunol. , vol.3 , pp. 11-19
    • Chiba, K.1    Matsuyuki, H.2    Maeda, Y.3    Sugahara, K.4
  • 52
    • 0037379202 scopus 로고    scopus 로고
    • Amelioration of experimental autoimmune encephalomyelitis in Lewis rats by FTY720 treatment
    • Fujino, M. et al. Amelioration of experimental autoimmune encephalomyelitis in Lewis rats by FTY720 treatment. J. Pharmacol. Exp. Ther. 305, 70-77 (2003).
    • (2003) J. Pharmacol. Exp. Ther. , vol.305 , pp. 70-77
    • Fujino, M.1
  • 53
    • 33745647822 scopus 로고    scopus 로고
    • Multiple sclerosis - FTY720, a novel once-daily oral medication, shows promising results
    • Medical News Today. [online]
    • Medical News Today. Multiple sclerosis - FTY720, a novel once-daily oral medication, shows promising results [online], (2005).
    • (2005)
  • 55
    • 0037097743 scopus 로고    scopus 로고
    • Effect of rapamycin on the cyclosporine-resistant CD28-mediated costimulatory pathway
    • Ghosh, P., Buchholz, M. A., Yano, S., Taub, D. & Longo, D. L. Effect of rapamycin on the cyclosporine-resistant CD28-mediated costimulatory pathway. Blood 99, 4517-4524 (2002).
    • (2002) Blood , vol.99 , pp. 4517-4524
    • Ghosh, P.1    Buchholz, M.A.2    Yano, S.3    Taub, D.4    Longo, D.L.5
  • 56
    • 0037732692 scopus 로고    scopus 로고
    • Transplant immunosuppressant agents and their role in autoimmune rheumatic diseases
    • Mayer, D. F. & Kushwaha, S. S. Transplant immunosuppressant agents and their role in autoimmune rheumatic diseases. Curr. Opin. Rheumatol. 15, 219-225 (2003).
    • (2003) Curr. Opin. Rheumatol. , vol.15 , pp. 219-225
    • Mayer, D.F.1    Kushwaha, S.S.2
  • 57
    • 16244377483 scopus 로고    scopus 로고
    • Predominant inhibition of interleukin-6 synthesis in patient-specific endothelial cells by mTOR inhibitors below a concentration range where cell proliferation is affected and mitotic arrest takes place
    • Lehle, K., Birnbaum, D. E. & Preuner, J. G. Predominant inhibition of interleukin-6 synthesis in patient-specific endothelial cells by mTOR inhibitors below a concentration range where cell proliferation is affected and mitotic arrest takes place. Transplant Proc. 37, 159-161 (2005).
    • (2005) Transplant Proc. , vol.37 , pp. 159-161
    • Lehle, K.1    Birnbaum, D.E.2    Preuner, J.G.3
  • 58
    • 17144373720 scopus 로고    scopus 로고
    • Inhibitors of the mammalian target of rapamycin
    • Dancey, J. E. Inhibitors of the mammalian target of rapamycin. Expert Opin. Investig. Drugs 14, 313-328 (2005).
    • (2005) Expert Opin. Investig. Drugs , vol.14 , pp. 313-328
    • Dancey, J.E.1
  • 60
    • 0038518197 scopus 로고    scopus 로고
    • The role of IL-17 and family members in the pathogenesis of arthritis
    • Lubberts, E. The role of IL-17 and family members in the pathogenesis of arthritis. Curr. Opin. Investig. Drugs 4, 572-577 (2003).
    • (2003) Curr. Opin. Investig. Drugs , vol.4 , pp. 572-577
    • Lubberts, E.1
  • 61
    • 27744586067 scopus 로고    scopus 로고
    • Small-molecule inhibition of TNF-α
    • Hee, M. M. et al. Small-molecule inhibition of TNF-α Science 11, 1022-1025 (2005).
    • (2005) Science , vol.11 , pp. 1022-1025
    • Hee, M.M.1
  • 62
    • 12144289400 scopus 로고    scopus 로고
    • A physical and functional map of the human TNF/NF-κB signal transduction pathway
    • Bouwmeester, T. et al. A physical and functional map of the human TNF/ NF-κB signal transduction pathway. Nature Cell Biol. 6, 97-105 (2004).
    • (2004) Nature Cell Biol. , vol.6 , pp. 97-105
    • Bouwmeester, T.1
  • 63
    • 0037292275 scopus 로고    scopus 로고
    • Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members
    • Janssens, S. & Beyaert, R. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol. Cell 11, 293-302 (2003).
    • (2003) Mol. Cell , vol.11 , pp. 293-302
    • Janssens, S.1    Beyaert, R.2
  • 64
    • 0037505362 scopus 로고    scopus 로고
    • The Toll-IL-1 receptor adaptor family grows to five members
    • O'Neill, L. A., Fitzgerald, K. A. & Bowie, A. G. The Toll-IL-1 receptor adaptor family grows to five members. Trends Immunol. 24, 286-290 (2003).
    • (2003) Trends Immunol. , vol.24 , pp. 286-290
    • O'Neill, L.A.1    Fitzgerald, K.A.2    Bowie, A.G.3
  • 65
    • 0038393016 scopus 로고    scopus 로고
    • IKKε and TBK1 are essential components of the IRF3 signaling pathway
    • Fitzgerald, K. A. et al. IKKε and TBK1 are essential components of the IRF3 signaling pathway. Nature Immunol. 4, 491-496 (2003).
    • (2003) Nature Immunol. , vol.4 , pp. 491-496
    • Fitzgerald, K.A.1
  • 66
    • 0038363463 scopus 로고    scopus 로고
    • Triggering the interferon antiviral response through an IKK-related pathway
    • Sharma, S. et al. Triggering the interferon antiviral response through an IKK-related pathway. Science 300, 1148-1151 (2003).
    • (2003) Science , vol.300 , pp. 1148-1151
    • Sharma, S.1
  • 67
    • 30544451546 scopus 로고    scopus 로고
    • Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6
    • Hacker, H. et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439, 204-207 (2006).
    • (2006) Nature , vol.439 , pp. 204-207
    • Hacker, H.1
  • 68
    • 30544447047 scopus 로고    scopus 로고
    • Critical role of TRAF3 in the Toll-like receptor-dependent and-independent antiviral response
    • Oganesyan, G. Critical role of TRAF3 in the Toll-like receptor-dependent and-independent antiviral response. Nature 439, 208-211 (2006).
    • (2006) Nature , vol.439 , pp. 208-211
    • Oganesyan, G.1
  • 69
    • 17844380477 scopus 로고    scopus 로고
    • Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction
    • Honda, K. et al. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 434, 1035-1040 (2005).
    • (2005) Nature , vol.434 , pp. 1035-1040
    • Honda, K.1
  • 70
    • 20244388983 scopus 로고    scopus 로고
    • IRAK-1 plays an essential role for TLR7- and TLR9-mediated interferon-α induction
    • Uematsu, S. et al. IRAK-1 plays an essential role for TLR7- and TLR9-mediated interferon-α induction. J. Exp. Med. 201, 915-923 (2005).
    • (2005) J. Exp. Med. , vol.201 , pp. 915-923
    • Uematsu, S.1
  • 71
    • 0037378466 scopus 로고    scopus 로고
    • Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium
    • Siebl, R. et al. Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium. Am. J. Pathol. 162, 1221-1227 (2003).
    • (2003) Am. J. Pathol. , vol.162 , pp. 1221-1227
    • Siebl, R.1
  • 72
    • 0037061453 scopus 로고    scopus 로고
    • Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
    • Leadbetter, E. A. et al. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416, 603-607 (2002).
    • (2002) Nature , vol.416 , pp. 603-607
    • Leadbetter, E.A.1
  • 73
    • 27744444832 scopus 로고    scopus 로고
    • RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement
    • Lau, C. M. et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J. Exp. Med. 202, 1171-1177 (2005).
    • (2005) J. Exp. Med. , vol.202 , pp. 1171-1177
    • Lau, C.M.1
  • 74
    • 0037596457 scopus 로고    scopus 로고
    • A low molecular weight mimic of Toll/IL-1 receptor/resistance domain inhibits IL-1 receptor-mediated responses
    • Bartfai, T. et al. A low molecular weight mimic of Toll/IL-1 receptor/ resistance domain inhibits IL-1 receptor-mediated responses. Proc. Natl Acad. Sci. USA 100, 7971-7976 (2003).
    • (2003) Proc. Natl Acad. Sci. USA , vol.100 , pp. 7971-7976
    • Bartfai, T.1
  • 75
    • 0037415598 scopus 로고    scopus 로고
    • The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defence
    • Harte, M. et al. The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defence. J. Exp. Med. 197, 343-351 (2003).
    • (2003) J. Exp. Med. , vol.197 , pp. 343-351
    • Harte, M.1
  • 76
    • 14044276319 scopus 로고    scopus 로고
    • Identification of a peptide derived from Vaccinia virus A52R protein that inhibits cytokine secretion in response to TLR-dependent signalling and reduces in vivo bacterial-induced inflammation
    • McCoy, S. L., Kurtz, S. E., MacArthur, C. J., Trune, D. R. & Hefeneider, S. H. Identification of a peptide derived from Vaccinia virus A52R protein that inhibits cytokine secretion in response to TLR-dependent signalling and reduces in vivo bacterial-induced inflammation. J. Immunol. 174, 3006-3014 (2005).
    • (2005) J. Immunol. , vol.174 , pp. 3006-3014
    • McCoy, S.L.1    Kurtz, S.E.2    MacArthur, C.J.3    Trune, D.R.4    Hefeneider, S.H.5
  • 77
    • 0347724170 scopus 로고    scopus 로고
    • RDP-58 (Sangstat medical)
    • Holtmann, M. M. RDP-58 (Sangstat medical). IDrugs 6, 1188-1194 (2003).
    • (2003) IDrugs , vol.6 , pp. 1188-1194
    • Holtmann, M.M.1
  • 78
    • 24644495105 scopus 로고    scopus 로고
    • RDP58 is a novel and potentially effective oral therapy for ulcerative colitis
    • Travis, S. et al. RDP58 is a novel and potentially effective oral therapy for ulcerative colitis. Inflamm. Bowel Dis. 11, 713-719 (2005).
    • (2005) Inflamm. Bowel Dis. , vol.11 , pp. 713-719
    • Travis, S.1
  • 79
    • 0035978533 scopus 로고    scopus 로고
    • A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
    • Ogura, Y. et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603-606 (2001).
    • (2001) Nature , vol.411 , pp. 603-606
    • Ogura, Y.1
  • 80
    • 0035978651 scopus 로고    scopus 로고
    • Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
    • Hugot, J. P. et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599-603 (2001).
    • (2001) Nature , vol.411 , pp. 599-603
    • Hugot, J.P.1
  • 81
  • 82
    • 4444253690 scopus 로고    scopus 로고
    • NOD2 is a negative regulator of TLR-2-mediated T helper Type I responses
    • Watanabe, T., Kitani, A., Murray, P. J. & Strober, W. NOD2 is a negative regulator of TLR-2-mediated T helper Type I responses. Nature Immunol. 5, 800-808 (2004).
    • (2004) Nature Immunol. , vol.5 , pp. 800-808
    • Watanabe, T.1    Kitani, A.2    Murray, P.J.3    Strober, W.4
  • 83
    • 13244277880 scopus 로고    scopus 로고
    • Nod2 mutation in Crohn's disease potentiates NF-κB activity and IL-1β processing
    • Maeda, S. et al. Nod2 mutation in Crohn's disease potentiates NF-κB activity and IL-1β processing. Science 307, 734-738 (2005).
    • (2005) Science , vol.307 , pp. 734-738
    • Maeda, S.1
  • 84
    • 32944470765 scopus 로고    scopus 로고
    • Cryopyrin activates the inflammasome in response to toxins and ATP
    • Mariathasan, S. et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440, 228-232 (2006).
    • (2006) Nature , vol.440 , pp. 228-232
    • Mariathasan, S.1
  • 85
    • 32944462834 scopus 로고    scopus 로고
    • Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3
    • Kanniganti, T. D. et al. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 440, 233-236 (2006).
    • (2006) Nature , vol.440 , pp. 233-236
    • Kanniganti, T.D.1
  • 86
    • 0037295235 scopus 로고    scopus 로고
    • Pralnacasan (Vertex pharmaceuticals)
    • Siegmund, B. & Zeitz, M. Pralnacasan (Vertex pharmaceuticals). IDrugs 6, 154-158 (2003).
    • (2003) IDrugs , vol.6 , pp. 154-158
    • Siegmund, B.1    Zeitz, M.2
  • 87
    • 1642285783 scopus 로고    scopus 로고
    • NALP3 forms an IL-1β-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder
    • Agostini, L. et al. NALP3 forms an IL-1β-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20, 319-325 (2004).
    • (2004) Immunity , vol.20 , pp. 319-325
    • Agostini, L.1
  • 88
    • 1642380180 scopus 로고    scopus 로고
    • Unravelling the NALP3/IL-1β inflammasome: A big lesson from a small mutation
    • Dinarello, C. A. Unravelling the NALP3/IL-1β inflammasome: A big lesson from a small mutation. Immunity 20, 243-246 (2004).
    • (2004) Immunity , vol.20 , pp. 243-246
    • Dinarello, C.A.1
  • 89
    • 32944468985 scopus 로고    scopus 로고
    • Gout-associated uric acid crystals activate the NALP3 inflammasome
    • Martinon, F., Petrilli, V., Mayor, A., Tardivel, A. & Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237-241 (2006).
    • (2006) Nature , vol.440 , pp. 237-241
    • Martinon, F.1    Petrilli, V.2    Mayor, A.3    Tardivel, A.4    Tschopp, J.5
  • 90
    • 24144465889 scopus 로고    scopus 로고
    • Molecular determinants of crosstalk between nuclear receptors and Toll-like receptors
    • Ogawa, S. et al. Molecular determinants of crosstalk between nuclear receptors and Toll-like receptors. Cell 122, 707-721 (2005).
    • (2005) Cell , vol.122 , pp. 707-721
    • Ogawa, S.1
  • 91
    • 0347065364 scopus 로고    scopus 로고
    • Interferon regulatory factor-3-mediated activation of the interferon-sensitive response element by Toll-like receptor (TLR) 4 but not TLR3 requires the p65 subunit of NF-κ
    • Wietek, C., Miggin, S. M., Jefferies, C. A. & O'Neill, L. A. Interferon regulatory factor-3-mediated activation of the interferon-sensitive response element by Toll-like receptor (TLR) 4 but not TLR3 requires the p65 subunit of NF-κ. J. Biol. Chem. 278, 50923-50931 (2003).
    • (2003) J. Biol. Chem. , vol.278 , pp. 50923-50931
    • Wietek, C.1    Miggin, S.M.2    Jefferies, C.A.3    O'Neill, L.A.4
  • 92
    • 5444253912 scopus 로고    scopus 로고
    • Ciclesonide: A novel inhaled corticosteroid
    • Humbert, M. Ciclesonide: A novel inhaled corticosteroid. Expert Opin. Investig. Drugs 13, 1349-1360 (2005).
    • (2005) Expert Opin. Investig. Drugs , vol.13 , pp. 1349-1360
    • Humbert, M.1
  • 93
    • 22944487652 scopus 로고    scopus 로고
    • Preclinical profile of ciclesonide, a novel corticosteroid for the treatment of asthma
    • Belvisi, M. G. et al. Preclinical profile of ciclesonide, a novel corticosteroid for the treatment of asthma. J. Pharmacol. Exp. Ther. 314, 568-574 (2005).
    • (2005) J. Pharmacol. Exp. Ther. , vol.314 , pp. 568-574
    • Belvisi, M.G.1
  • 94
    • 20444439570 scopus 로고    scopus 로고
    • PPAR-γ modulates allergic inflammation through up-regulation of PTEN
    • Lee, K. S. PPAR-γ modulates allergic inflammation through up-regulation of PTEN. FASEB J. 19, 1033-1035 (2005).
    • (2005) FASEB J. , vol.19 , pp. 1033-1035
    • Lee, K.S.1
  • 95
    • 3843118877 scopus 로고    scopus 로고
    • New advances and potential therapies for the treatment of asthma
    • Belvisi, M. G., Hele, D. J. & Birrell, M. A. New advances and potential therapies for the treatment of asthma. BioDrugs 18, 211-223 (2004).
    • (2004) BioDrugs , vol.18 , pp. 211-223
    • Belvisi, M.G.1    Hele, D.J.2    Birrell, M.A.3
  • 96
    • 0032565868 scopus 로고    scopus 로고
    • Activation of human aortic smooth-muscle cells is inhibited by PPAR-α but not PPAR-γ activators
    • Staels, B. et al. Activation of human aortic smooth-muscle cells is inhibited by PPAR-α but not PPAR-γ activators. Nature 393, 790-793 (1998).
    • (1998) Nature , vol.393 , pp. 790-793
    • Staels, B.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.